Common Effects Ozempic may cause nausea, vomiting, diarrhea, constipation, decreased appetite, mild abdominal pain, injection-site reactions, and occasional dizziness
This shows that semaglutide has good cardiovascular safety, but compared with subcutaneous injections, oral formulations have no advantage in reducing the occurrence of cardiovascular events in high-risk groups
Injection technique for retatrutide Proper injection technique ensures consistent absorption and minimizes injection site reactions
Staying well hydrated helps
The patient has already demonstrated that they respond to the medication at this total dose, and the modification addresses tolerability without changing efficacy expectations